NASDAQ:BBOT | Income Statement | BridgeBio Oncology Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2023-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$49.23M$60.19M-$60.19M$3.73M$0.00-$56.45M-$705.20-$705.2080,054,00080,054,000
2026-03-31$39.8M$46.18M-$46.18M$4.07M-$42.11M-$526.11-$526.1180,03280,032
2025-12-31$38.07M$43.41M-$43.41M$4.61M$0.00-$38.8M$2.19$2.1916,459,78516,459,785
2025-09-30$35.05M$49.18M-$49.18M$4.42M$0.00-$44.76M-$1.03-$1.0343,491,08543,491,085
2025-06-30$27.44M$30.09M-$30.09M$1.66M$0.00-$28.44M-$566.46-$566.4650,198,00050,198,000
2025-03-31$20.64M$23.14M-$23.14M$1.08M$0.00-$22.06M-$54.23-$54.23406,723406,723
2024-12-31$19.54M$21.88M-$21.88M$2.19M$0.00-$19.69M-$833.69-$833.691,8141,814
2024-09-30$17.89M$19.66M-$19.66M$2.34M$0.00-$17.32M-$1,562.18-$1,562.1811,08911,089
2024-06-30-$152,343.00$2.36M-$21.82M
2024-03-31-$66,701.00$1.17M-$15.44M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$121.2M$145.82M-$145.82M$11.78M$0.00-$134.04M-$4.30-$4.3031,144,77531,144,775
2024-12-31$73.11M$80.86M-$80.86M$6.59M$0.00-$74.28M-$5,756.41-$5,756.4112,90312,903
2023-12-31-$41,692.00-$41,692.00